32.50.Z - Production of medical devices, instruments, and products, including dental products
32.99.Z - Production of other products not classified elsewhere
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
64.92.Z - Other forms of credit granting
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
72.19.Z - Scientific research and development activities
72.20.Z - Scientific research and development in social sciences and humanities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 12,4 | -1,4 | -16,4 | -1039,9 |
EBITDA | 16,2 | -1,4 | -28 | -1916,1 |
Short time liabilities | 4,4 | 29,6 | 34,7 | 17,5 |
Equity capital | 41,5 | 41,5 | 21,1 | -49,2 |
Operating profit (EBIT) | 12,3 | 0,4 | -18,5 | -4264,1 |
Assets | 63,1 | 192,7 | 223 | 15,7 |
Net profit (loss) | 11,2 | -0 | -20,4 | -298 299,7 |
Cash | 2,9 | 11,5 | 18,7 | 63,1 |
Liabilities and provisions for liabilities | 21,6 | 151,2 | 201,9 | 33,5 |
Net income from sale | 26,6 | 39,5 | 45,4 | 15 |
Working assets | 26,7 | 35,3 | 36,4 | 3,2 |
Depreciation | 3,9 | -1,8 | -9,5 | -416,1 |
% | % | % | p.p. | |
Profitability of capital | 27,1 | -0 | -96,7 | -96,7 |
Equity capital to total assets | 65,7 | 21,5 | 9,5 | -12 |
Gross profit margin | 46,4 | -3,6 | -36,2 | -32,6 |
EBITDA Margin | 60,7 | -3,5 | -61,6 | -58,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 60 | 273 | 279 | 6 |
Current financial liquidity indicator | 2.2655177116394043 | 1.0899730920791626 | 0.9609531760215759 | -0,1 |
Net dept to EBITDA | 0.48843419551849365 | -77.56385040283203 | -5.202393054962158 | 72,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane